ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 103 filers reported holding ALBIREO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,065,287 | +17.5% | 49,296 | +5.3% | 0.00% | – |
| Q3 2022 | $907,000 | -1.4% | 46,834 | +1.1% | 0.00% | – |
| Q2 2022 | $920,000 | -33.2% | 46,319 | +0.4% | 0.00% | – |
| Q1 2022 | $1,377,000 | +29.1% | 46,147 | +0.8% | 0.00% | – |
| Q4 2021 | $1,067,000 | -23.0% | 45,772 | +3.1% | 0.00% | – |
| Q3 2021 | $1,386,000 | -7.4% | 44,414 | +4.5% | 0.00% | – |
| Q2 2021 | $1,496,000 | -1.0% | 42,504 | -0.8% | 0.00% | -100.0% |
| Q1 2021 | $1,511,000 | -4.2% | 42,841 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $1,578,000 | +43.3% | 42,059 | +27.5% | 0.00% | 0.0% |
| Q3 2020 | $1,101,000 | +21.0% | 32,982 | -3.9% | 0.00% | – |
| Q2 2020 | $910,000 | +69.5% | 34,329 | +4.8% | 0.00% | – |
| Q1 2020 | $537,000 | -26.0% | 32,753 | +14.8% | 0.00% | – |
| Q4 2019 | $726,000 | +45.2% | 28,532 | +14.2% | 0.00% | – |
| Q3 2019 | $500,000 | -34.3% | 24,983 | +6.0% | 0.00% | – |
| Q2 2019 | $761,000 | +15.5% | 23,576 | +15.3% | 0.00% | – |
| Q1 2019 | $659,000 | +40.5% | 20,440 | +7.0% | 0.00% | – |
| Q4 2018 | $469,000 | -25.6% | 19,099 | 0.0% | 0.00% | – |
| Q3 2018 | $630,000 | -7.2% | 19,099 | 0.0% | 0.00% | – |
| Q2 2018 | $679,000 | – | 19,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |